SE443087B - COMPOSITION OF INHALATION COMPOSITION OF DISINODIUM CHROMOGLYCT AND LECITIN OR A SORBITAN OR SORBITOL ESTER IN A MIXTURE OF DICHLORDIFLUORMETHANE AND 1,2-DICHLOR-1,1,2,2-TETRAFLUORETHANE - Google Patents
COMPOSITION OF INHALATION COMPOSITION OF DISINODIUM CHROMOGLYCT AND LECITIN OR A SORBITAN OR SORBITOL ESTER IN A MIXTURE OF DICHLORDIFLUORMETHANE AND 1,2-DICHLOR-1,1,2,2-TETRAFLUORETHANEInfo
- Publication number
- SE443087B SE443087B SE7807934A SE7807934A SE443087B SE 443087 B SE443087 B SE 443087B SE 7807934 A SE7807934 A SE 7807934A SE 7807934 A SE7807934 A SE 7807934A SE 443087 B SE443087 B SE 443087B
- Authority
- SE
- Sweden
- Prior art keywords
- weight
- sorbitan
- composition
- composition according
- ester
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Description
7807954-0 2 Vid framställning av suspensionen stelnar det ytaktiva ämnet, men det dispergeras lätt såsom små inbördes åtskilda partiklar i blandningen av drivmedel 12 och drivmedel 114. De resulterande dispersionerna är vanligen stabila under minst 30 minuter. In preparing the suspension, the surfactant solidifies, but it is easily dispersed as small spaced particles in the mixture of propellant 12 and propellant 114. The resulting dispersions are usually stable for at least 30 minutes.
Dispersionen av det ytaktiva ämnet i blandningen av drivmed- len 12 och 114 kan blandas med det finfördelade dinatriumkromoglyka- tet, som bör torkas före användningen. Dispersionens halt av det finfördelade dinatriumkromoglykatet är företrädesvis 0 ,1-10 ,0 vikt- procent och allra helst 1-5 viktprocent. Ytterligare drivmedel 12 och/eller drivmedel 114 (kylt på lämpligt sätt, t.ex. till -50°C) kan sättas till den ursprungliga dispersionen eller den ursprungliga dispersionen innehållande det finfördelade dinatriumkromoglykatet.The dispersion of the surfactant in the mixture of the fuels 12 and 114 can be mixed with the finely divided disodium chromoglycate, which should be dried before use. The dispersion content of the atomized disodium cromoglycate is preferably 0, 1-10, 0% by weight and most preferably 1-5% by weight. Additional propellant 12 and / or propellant 114 (suitably cooled, eg to -50 ° C) may be added to the original dispersion or the original dispersion containing the atomized disodium cromoglycate.
Viktförhållandet mellan drivmedel 12 och drivmedel 114 i den slutliga blandningen är såsom nämnts mellan 2:1 och 1:1, före- trädesvis ca 1,5:1. Ett överskott av drivmedel 12 i förhållande till drivmedel 114 föredrages sålunda.The weight ratio of propellant 12 to propellant 114 in the final mixture is, as mentioned, between 2: 1 and 1: 1, preferably about 1.5: 1. Thus, an excess of propellant 12 relative to propellant 114 is preferred.
Dispersionen eller suspensionen av det ytaktiva ämnet i den slutliga blandningen av drivmedlen 12 och 114 innehåller lämpligen 0,15-2,0 viktprocent lecitin eller sorbitan- eller sorbitolester, företrädesvis 0,2-1,2 viktprocent. Dessutom innehåller dylika disper- sioner eller suspensioner lämpligen 0,05-2,0 viktprocent dinatrium- kromoglykat, företrädesvis 0,2-2,0 viktprocent.The dispersion or suspension of the surfactant in the final mixture of propellants 12 and 114 suitably contains 0.15-2.0% by weight of lecithin or sorbitan or sorbitol ester, preferably 0.2-1.2% by weight. In addition, such dispersions or suspensions suitably contain 0.05-2.0% by weight of disodium chromoglycate, preferably 0.2-2.0% by weight.
Dispersioner av 0,2-2 viktdelar sorbitanester i en blandning av 50-70 viktdelar drivmedel 12 och 50-30 viktdelar 114 är stabila under minst 16 timmar vid en temperatur av -60oC.Dispersions of 0.2-2 parts by weight of sorbitan ester in a mixture of 50-70 parts by weight of propellant 12 and 50-30 parts by weight of 114 are stable for at least 16 hours at a temperature of -60 ° C.
Man föredrager särskilt sådana dispersioner, i vilka det yt- aktiva ämnet är en sorbitanester, t.ex. sorbitantrioleat ("Span 8Û"b.Particularly preferred are such dispersions in which the surfactant is a sorbitan ester, e.g. sorbitan trioleate ("Span 8Û" b.
När lecitin användes, är detta företrädesvis vegetabiliskt, t.ex. sojalecitin.When lecithin is used, it is preferably vegetable, e.g. sojalecitin.
Kompositionerna enligt uppfinningen bör innehålla mindre än 1,0 viktprocent vatten, företrädesvis mindre än 0,5 viktprocent vat- ten och allra helst mindre än 0,2 viktprocent vatten.The compositions of the invention should contain less than 1.0% by weight of water, preferably less than 0.5% by weight of water and most preferably less than 0.2% by weight of water.
Vissa kompositioner enligt uppfinningen är fördelaktiga jäm- fört med motsvarande kompositioner innehållande drivmedel 11 genom att de antingen ger en högre andel av fina partiklar i det bildade aerosolmolnet eller kan användas för framställning av dylika kompo- sitioner. En lämplig metod för bestämning av andelen fina partiklar i ett aerosolmoln beskrives i J. Phar. Pharmac. 1973, 25, Suppl. 32?-36P. 7807934-0 3 Man har överraskande funnit, att i inhalationskompositioner innehållande dinatriumkromoglykat ett viktförhållande 12:114 från 2:1 till 1:1 ger bättre resultat än ett viktförhållande lägre än 1:1. För att visa detta har man jämfört tvâ dinatriumkromoglykat- kompositioner, vilka skiljer sig åt endast vad avser förhållandet 12:114. Man har sålunda jämfört två kompositioner A och B, där komposition A är en komposition enligt uppfinningen med ett vikt- förhållande drivmedel 12:drivmedel 114 av 3:2, medan komposition B är en komposition som icke omfattas av uppfinningen (viktförhållan- det 12:114 är 2:3, dvs. det föredragna förhållandet enligt GB 988 513).Certain compositions according to the invention are advantageous over corresponding compositions containing propellant 11 in that they either give a higher proportion of fine particles in the aerosol cloud formed or can be used for the preparation of such compositions. A suitable method for determining the proportion of fine particles in an aerosol cloud is described in J. Phar. Pharmac. 1973, 25, Suppl. 32? -36P. It has surprisingly been found that in inhalation compositions containing disodium cromoglycate a weight ratio of 12: 114 from 2: 1 to 1: 1 gives better results than a weight ratio lower than 1: 1. To show this, two disodium cromoglycate compositions have been compared, which differ only in the ratio 12: 114. Thus, two compositions A and B have been compared, where composition A is a composition according to the invention with a weight ratio propellant 12: propellant 114 of 3: 2, while composition B is a composition not covered by the invention (weight ratio 12: 114 is 2: 3, i.e. the preferred ratio according to GB 988 513).
De viktigaste skillnaderna mellan de båda kompositionerna är följande: (1) Komposition B tenderar att bilda aggregat, och suspensio- nen har dålig fysikalisk stabilitet. (2) Ett dispergeringstest visar att komposition A ger unge- fär dubbelt så hög andel fina partiklar i det bildade aerosolmol- net som komposition B. En hög andel fina partiklar i aerosolmolnet är av stor betydelse när det gäller en inhalationskompositions förmåga att tränga djupt ned i lungorna.The main differences between the two compositions are as follows: (1) Composition B tends to form aggregates, and the suspension has poor physical stability. (2) A dispersion test shows that composition A gives about twice as high a proportion of fine particles in the formed aerosol cloud as composition B. A high proportion of fine particles in the aerosol cloud is of great importance in the ability of an inhalation composition to penetrate deeply in the lungs.
De jämförande försöksresultaten visar, att komposition B har försämrats avsevärt efter enbart 3,5 månader under relativt milda betingelser vid rumstemperatur. Komposition A uppvisar däremot endast obetydligt försämrade egenskaper efter 4 års lagring vid rumstemperatur.The comparative test results show that composition B has deteriorated considerably after only 3.5 months under relatively mild conditions at room temperature. Composition A, on the other hand, shows only slightly degraded properties after 4 years of storage at room temperature.
Uppfinningen illustreras genom följande utföringsexempel.The invention is illustrated by the following working examples.
Exempel. Sprayförpackningar framställdes på följande sätt.Example. Spray packages were prepared as follows.
En sorbitanester dispergeras i upp till halva mängden drivmedel 12 vid -40OC under omrörning med en blandare som ger en hög disper- sionsgrad. Torkat finmalt dinatriumkromoglykat sättes till den resulterande dispersionen, varvid detta ämne är mycket lätt att dispergera. Resten av drivmedel 12 tillsättes därefter vid -SOOC, varefter drivmedel 114 tillsättes, också kylt till -SOOC. Den resulterande blandningen fylles på tryckbehâllare, på vilka ven- tiler, t.ex. mätventiler, därefter anbringas.A sorbitan ester is dispersed in up to half the amount of propellant 12 at -40 ° C with stirring with a mixer which gives a high degree of dispersion. Dried finely ground disodium cromoglycate is added to the resulting dispersion, this substance being very easy to disperse. The remainder of propellant 12 is then added at -SOOC, after which propellant 114 is added, also cooled to -SOOC. The resulting mixture is filled into pressure vessels, on which valves, e.g. measuring valves, then fitted.
Man framställde kompositioner med följande sammansättning:Compositions having the following composition were prepared:
Claims (6)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3016977 | 1977-07-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7807934L SE7807934L (en) | 1979-01-20 |
SE443087B true SE443087B (en) | 1986-02-17 |
Family
ID=10303374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7807934A SE443087B (en) | 1977-07-19 | 1978-07-18 | COMPOSITION OF INHALATION COMPOSITION OF DISINODIUM CHROMOGLYCT AND LECITIN OR A SORBITAN OR SORBITOL ESTER IN A MIXTURE OF DICHLORDIFLUORMETHANE AND 1,2-DICHLOR-1,1,2,2-TETRAFLUORETHANE |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS5435209A (en) |
AU (1) | AU522792B2 (en) |
BE (1) | BE869055A (en) |
CA (1) | CA1112567A (en) |
CH (1) | CH627075A5 (en) |
DE (1) | DE2831419A1 (en) |
FR (1) | FR2397833A1 (en) |
HK (1) | HK51585A (en) |
IE (1) | IE47128B1 (en) |
IL (1) | IL55161A (en) |
IT (1) | IT1158890B (en) |
MY (1) | MY8400252A (en) |
NL (1) | NL7807625A (en) |
NZ (1) | NZ187894A (en) |
SE (1) | SE443087B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8501015D0 (en) * | 1985-01-16 | 1985-02-20 | Riker Laboratories Inc | Drug |
HU205249B (en) * | 1990-11-09 | 1992-04-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing suspensive aerosole composition |
DE4425255A1 (en) | 1994-07-16 | 1996-01-18 | Asta Medica Ag | Formulation for inhalation application |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB367276A (en) * | 1931-06-20 | 1932-02-18 | Schmidt Sche Heissdampf | Improvements in or relating to independently fired steam superheaters |
BE555319A (en) * | 1956-03-21 | 1900-01-01 | ||
BE556587A (en) * | 1957-01-31 | 1957-04-11 | ||
GB1144905A (en) * | 1965-03-25 | 1969-03-12 | Fisons Pharmaceuticals Ltd | Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof |
US3513104A (en) * | 1965-03-26 | 1970-05-19 | Colgate Palmolive Co | Self-propelling powder compositions |
US3560507A (en) * | 1968-02-27 | 1971-02-02 | Millmaster Onyx Corp | Quaternary ammonium alkenyl succinates |
GB1384895A (en) * | 1971-01-25 | 1975-02-26 | Colgate Palmolive Co | Fabric conditioning |
DE2151706B1 (en) * | 1971-10-18 | 1973-05-03 | Cegla, Ulrich, Dr med , 600 0 Frank fürt Niederrad | Tantalum-contg x-ray contrast agents - in aerosol form for bronchography |
IL44022A0 (en) * | 1973-01-23 | 1974-05-16 | Fisons Ltd | Novel salts of anti-inflammatory quinoline derivatives,their preparation and pharmaceutical compositions containing them |
IT1039699B (en) * | 1975-07-03 | 1979-12-10 | Prephar | SPERMICIDE COMPOSITION BASED ON BENZISOTHIAZOLIC DERIVATIVES |
GB1562901A (en) * | 1976-01-30 | 1980-03-19 | Fisons Ltd | Disodium cromoglycate |
FI770215A (en) * | 1976-01-30 | 1977-07-31 | Fisons Ltd | |
GB2001334B (en) | 1977-07-19 | 1982-03-03 | Fisons Ltd | Pressurised aerosol formulation |
GB1590126A (en) | 1977-11-23 | 1981-05-28 | Booth B H | Method of bulking yarns |
-
1978
- 1978-07-14 AU AU38057/78A patent/AU522792B2/en not_active Expired
- 1978-07-17 NL NL7807625A patent/NL7807625A/en active Search and Examination
- 1978-07-17 IE IE1432/78A patent/IE47128B1/en not_active IP Right Cessation
- 1978-07-17 FR FR7821172A patent/FR2397833A1/en active Granted
- 1978-07-17 CA CA307,480A patent/CA1112567A/en not_active Expired
- 1978-07-17 BE BE189326A patent/BE869055A/en not_active IP Right Cessation
- 1978-07-18 DE DE19782831419 patent/DE2831419A1/en active Granted
- 1978-07-18 SE SE7807934A patent/SE443087B/en not_active IP Right Cessation
- 1978-07-18 NZ NZ187894A patent/NZ187894A/en unknown
- 1978-07-18 IT IT25845/78A patent/IT1158890B/en active Protection Beyond IP Right Term
- 1978-07-18 IL IL55161A patent/IL55161A/en unknown
- 1978-07-18 JP JP8682578A patent/JPS5435209A/en active Granted
- 1978-07-18 CH CH774178A patent/CH627075A5/en not_active IP Right Cessation
-
1984
- 1984-12-30 MY MY252/84A patent/MY8400252A/en unknown
-
1985
- 1985-07-04 HK HK515/85A patent/HK51585A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IT1158890B (en) | 1987-02-25 |
DE2831419C2 (en) | 1989-01-05 |
MY8400252A (en) | 1984-12-31 |
FR2397833B1 (en) | 1982-06-25 |
HK51585A (en) | 1985-07-12 |
JPS6411615B2 (en) | 1989-02-27 |
AU3805778A (en) | 1980-01-17 |
IL55161A (en) | 1981-12-31 |
CA1112567A (en) | 1981-11-17 |
AU522792B2 (en) | 1982-06-24 |
CH627075A5 (en) | 1981-12-31 |
NZ187894A (en) | 1984-05-31 |
IE47128B1 (en) | 1983-12-28 |
IT7825845A0 (en) | 1978-07-18 |
BE869055A (en) | 1979-01-17 |
SE7807934L (en) | 1979-01-20 |
FR2397833A1 (en) | 1979-02-16 |
IE781432L (en) | 1979-01-19 |
NL7807625A (en) | 1979-01-23 |
JPS5435209A (en) | 1979-03-15 |
IL55161A0 (en) | 1978-09-29 |
DE2831419A1 (en) | 1979-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3738852A (en) | Cationic bituminous emulsion | |
SE442267B (en) | PROCEDURE FOR PREPARING A PHARMACEUTICAL COMPOSITION CONTAINING THE DINATRIUM SALT OF 1,3-BIS (2-CARBOXICROMON-5-YLOXI) PROPAN-2-OL | |
SE414704B (en) | PROCEDURE FOR THE MANUFACTURING OF PRICK-FORCING GRAIN WITH MAIN UNIQUE FORM AND SIZE FOR DENTALS | |
SE438275B (en) | MIX-FREE IRON-BASED POWDER MIX | |
CA1097072A (en) | Halogenated organic compound with metal fuel and silver iodate as pyrotechnic cloud seeding composition | |
SE443087B (en) | COMPOSITION OF INHALATION COMPOSITION OF DISINODIUM CHROMOGLYCT AND LECITIN OR A SORBITAN OR SORBITOL ESTER IN A MIXTURE OF DICHLORDIFLUORMETHANE AND 1,2-DICHLOR-1,1,2,2-TETRAFLUORETHANE | |
US3085889A (en) | Emulsions stabilized against freezing | |
DE2348926A1 (en) | FIXED FIRE EXTINGUISHING COMPOSITIONS | |
EP0067560B1 (en) | Gelatinized highly explosive composition and method of preparation | |
DE1719443C3 (en) | ||
US2356776A (en) | Composition for preparation of oil base drilling fluid | |
US2506635A (en) | Ddt insecticide dust and process for making same | |
US2733139A (en) | Cast explosive composition | |
JPH03157327A (en) | Powdery aerosol composition | |
US3166555A (en) | Ammonium nitrate-hexamethylene-tetramine adduct | |
US2922703A (en) | Incendiary fuels | |
US2159999A (en) | Preventing the caking of sodium perborate | |
Francis Jr | A note on the use of magnesium oxide in combustion tube fillings | |
US2820761A (en) | Carbon dioxide composition | |
US3197321A (en) | Spray composition | |
US2168563A (en) | Nitrostarch explosive | |
GB669709A (en) | Procaine-penicillin g composition | |
GB841304A (en) | Improvements in or relating to additive materials for rendering cement water resistant | |
DE2835494A1 (en) | Prodn. of porous rubber articles - using eutectic mixtures of urea-acetamide-emulsifier which are homogeneously distributed | |
SU802326A1 (en) | Polimeric composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7807934-0 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 7807934-0 Format of ref document f/p: F |